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Sex-dependent differences in
phenobarbitone-induced oestradiol-2-
hydroxylase activity in rat liver
C. N. THERON, A. C. NEETHLlNG, J. J. F. TALJAARD
Summary
Oestradiol-2-hydroxylase (E2-OH) activity. was
measured in liver and brain microsomes of 6-8-
week-old Wistar rats. Phenobarbitone (75 mg/kg
daily for 3 days) significantly increased enzyme
activity in the liver of males and females, but there
were stri~ing differences between the two sexes. In
males the enzyme activity was increased by 37%
over control values and in females by 200%. The
total microsomal cytochrome P-450 content was
increased by 75% in males and by 82% in females.
The apparent Michaelis constant (Km) of E2-OH for
17B-oestradiol in untreated males (9;8 ",M) and
females (9,2 flM) did not differ significantly.
Phenobarbitone treatment, however, tended to
reduce tfie apparent Km in males (8,2 flM) and to
increase it in>females (18,7 flM). E2-OH activity was
also detected in brain tissue of both sexes, but it was
. 50-200-fold lower than in the liver and was not
increased by phenobarbitone.
S. Air. med. J .• 60, 279 (1981).
The existence of sexual differences in the hepatic metabolism of
steroids and drugs is well known. 1,2 Male rats, for example,
metabolize hexobarbitone and ethylmorphine 2-4 times faster
than females. 3 These sex-dependent patterns of drug
metabolism appear to be imprinted by the steroid environment
to which the animal is exposed in the neonatal period. The male
pattern of ethylmorphine metabolism in rats, for example, is
dependent on the presence of testosterone shortly after birth. 4
Over the past few years it has also become clear that the pituitary
gland may be involved in maintaining the neonatally imprinted
sexual patterns of hepatic drug metabolism, I
Several steroid-metabolizing enzymes which show sex-
dependent differences in activity have been studied, but
relatively little is known about oestradiol-2-hydroxylase (E2-
OH) in this respect. In recent years this enzyme has attracted
considerable attention because it catalyses the formation of
catechol oestrogens which are thought to play an important role
in neuro-endocrine regulation.5' 9 The recent introduction of an
extremely sensitive assay for E2-OH7 has greatly simplified the
investigation of this enzyme. It has been detected in several
tissues, the liver having by far the highest activity, followed by
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the brain. 8 Most of the enzyme activity is present in microsomes
and there is good evidence that E2-OH belongs to the
cytochrome P-450 group of mono-oxygenases.7' S The activity of
the enzyme is higher in male rats than in females and it is lowered
in males by castration.s
\Ve undertook the present investigation to obtain more
information about sex-dependent differences in E2-OH activity.
In addition we wanted to find out whether it can be induced by
phenobarbitone treatment, since this drug is known to increase
the metabolic clearance rate of many steroids. lo Furthermore,
phenobarbitone treatment of pregnant rats affects the sexual
functions of female offspring. I I In the present article we shall
present evidence that phenobarbitone treatment increases the
E2-OH activity in the liver of Wistar rats and that there are
important sexual differences in this respect.
Materials and methods
Chemicals
All chemicals, unless otherwise specified, were of analytical
grade and were obtained from E. Merck, Darmstadt, \Vest
Germany. The l7R-oestradiol was purchased from' Sigma
Chemical Co., St Louis, Mo., USA, and NADPH from
Boehringer Mannheim, Mannheim, W. Germany.' Catechol-o-
methyltransferase (COMT) was prepared by us from fresh ox
liver, essentially according to the method described by Axelrod
and Tomchick l2 and modified by Nikodejevick el al. 13 S-[3H]
methyl adenosylmethionine (specific activity 11,8-13,5
Ci/mmol) was obtained from New England Nuclear Corp.,
Cambridge, Mass., USA.
Animals and drug treatment
Male and female Wistar rats, 6-8 weeks old and weighing 150-
200 g, were used. They were housed in plastic cages with wire
mesh flooring under diurnal lighting and they had free access to
food (standard Epol pellets) and water. The rats were injected
intraperitoneally with sodium phenobarbitone dissolved in 0,9%
NaCI or with 0,9 NaCI only (controls). The phenobarbitone
injection schedule for each animal was 75 mg/kg once a day for 3
days. After the last injection the rats were fasted for 18 hours
before being killed, but water was allowed freely.
Preparation of microsomes
The rats were killed by decapitation and tissues were rapidly
removed and placed in ice-cold buffered isotonic KCl (0,154M
KCI: 50 mM tris, pH 7,4). For each experiment tissues from 3-6
animals (control and phenobarbitone-treated groups
respectively) were pooled. Livers were minced with scissors
before homogenization. The tissues were homogenized in the
buffered isotonic KCI (4 ml/g tissue) in a Potter-Elvehejm
homogenizer with a Teflon pestle driven by an 1/15 hp stirrer
(Tri-R instruments, Rockville Centre, NY, USA). For both
brain and liver 10 passes at half the maximum setting of the
instrument were used.
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Microsomes were prepared by means of standard differential
centrifugation methods. Brain homogenates were centrifuged
once at 12000 g for 20 minutes and the resulting supernatant was
then centrifuged at 105000 g for 60 minutes to pellet
microsomes. The liver homogenates were treated slightly
differently in that they were centrifuged twice at 12000 g for 15
minutes. The second 12000 g supernatant was then carefully
aspirated off to about 2 cm above the pellet and centrifuged at
105000 g for 60 minutes. Microsomal pellets were rinsed twice in
ice-cold isotonic KCI and were then suspended by
homogenization in isotonic KCl-tris to give protein
concentrations of about 3 mg/ml (brain) and 10 mg/m! (liver).
The protein concentration of microsomal suspensions was
measured by the method of Lowry el al. I. Tissues and
microsomes were kept at 0-4°C during the preparation.
Oestradiol-2-hydroxylase assay
El-OH activity was assayed by the method of Paul el al. 7 In
this method the hydroxylation of 17B-oestradiol is coupled with
rapid a-methylation by means of COMT. A radioactive methyl
group is derived from S-[3H]-methyl adenosylmethionine. The
resulting iH-methoxy oestrogens are stable and can be extracted
with n-heptane. The specificity o(the assay has been confirmed
by chromatographic and mass spectroscopic analysis of the
heptane-extractable radioactive products. More than 90% of
these represented methoxy-oestrogens (2-methoxy-oestradiol
and 2-hydroxy-oestradiol-3-methyl ether7).
Each reaction tube contained the following reagents: 5 /11
0, 154M KCI, 50mM tris (pH 7,4), 1O/111M MgC12, 5 /-ll (2,5 /-lCi)
S-[3H]-methyl adenosylmethionine (sp. activity 11,8-13,5
Ci/mmol), 20 /11 COMT, 5 /11 10 mM ascorbic acid, 5 /-ll
0,0135M NADPH, 50 /-ll microsomal suspension and 17 B-
oestradiol in 2 /-ll absolute ethanol. All the reagents, except S-
[3H]-methyl adenosylmethionine, COMT and oestradiol, were
dissolved in the buffered isotonic KCl (pH 7,4) and were freshly
prepared just before the experiment. Each reaction tube
contained 20-30 /1g microsomal protein (liver), or 100-150 /1g
microsomes (brain). The total volume of the reaction mixture
was 102/11 and it was kep_ in crushed ice until all the reagents had
been added. Blanks, consisting of all the reagents plus 50 /11 of
heat-inactivated microsomes, were included in all the
experiments.
The reaction was starred by placing the tubes in a shaking
water-bath at 37°C. After 10 minutes' incubation the reaction
was stopped by adding 0,5 ml 0,5M borate buffer (pH 10). The
radioactive methoxy-oestrogen was then extracted with 6 ml
heptane by vigorous shaking for 30 seconds, followed by
centrifugation to separate the heprane from the watery phase.
Two-millilitre aliquots of the heptane extract were then pipened
into counting vials and evaporated to dryness in an oven at 90°C.
To each vial 10 ml Insta-Gel (Packard Instrument Co.,
Downer's Grove, Ill., USA) was added and radioactivity
measured in a Beckman LS 9000 scintillation counter. The
amount of methoxy-oesrrogen formed was expressed as
picomoles per milligram microsomal protein per 10 minutes'
incubation and was directly calculated from the specific activity
of the S-[3H]-methyl adenosylmethionine.
Apparent Michaelis constant (Km)
The apparent Km of E2-OH was determined by assaying as
described above with different concenuations of 17B-oestradiol
ranging from 7 to 150 /1M. The reciprocals of the subsuate
concentrations were then ploned against the reciprocals of the
reaction velocities (Lineweaver-Burke plot) to determine the
relevant kinetic parameters.
Cytochrome P-450 measurement
The total cytochrome P-450 comeht of liver microsomes was
measured essentially as described by Estabrook er al. 15
Microsomes were suspended in 0,154M KCl, 50 mM tris (pH
7,4) to give a protein concentration of 1-2 mg/ml. Six millilitres
of the suspension was then gassed with carbon monoxide for 2-3
minutes and the suspension equally divided into two cuvenes
and a baseline of equal light absorbance recorded with a
Beckman 5260 dual-beam spectrophotometer. A few crystals of
sodium dithionite were then added to the sample cuvene and the
difference spectrum was recorded between 390 and 510 nrn. The
CO complex of reduced cytochrome P-450 gave a well-defined
absorbance peak at 450 nm. By using a millimolar extinction
coefficient of 100 for the difference in absorbance at 450 minus
510, cytochrome P-450 could be quantified.
Results
Oestrogen-2-hydroxylase activity
in brain and liver tissue
The E2-OH activities in brain and liver are compared in Table
1. In both sexes the liver had a much higher enzyme activity than
the brain. Furthermore, enzyme activity in the liver ofmales was
about fourfold higher than in females. There was, however, no
significant difference between the sexes in respect of enzyme
activity in the brain.
Effect of phenobarbitone treatment on
enzyme activity
Phenobarbitone, in a daily dose of75 mg/kg for 3 days, had no
significant effect on E2-OH activity in the brain tissue of male or
female rats. In the liver, on the other hand, phenobarbitone
caused a significant increase in enzyme activity in both sexes
(Table I). There was, however, a most sttiking difference
TABLE I. E2-OH ACTIVITY' IN BRAIN AND LIVER OF RATS
Brain Liver
Male Female Male Female
Treatment Mean SEM Mean SEM Mean SEM Mean SEM
None 4,9 ±O,712 6,0 1477 ± 68,41 367 ± 47,62
(3) (1 ) (7) (2)
Phenobarbitone 4,2 ±O,498 5,4 2029 ±119,22 1108 ±116,02
(3) (1 ) (6) (2)
NS NS P < 0,01 P < 0,01
• E2-OH activity is expressed as pmol methoxy-oestrogen formed per mg microsomal protein per 10 minutes' incubation at 37°C. The values given
represent the means (± SE) of the number of experiments (N) stated in brackets. In each experiment tissues from 3-6 animals were pooled.
Statistical significance was determined by means of the t test.
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between the sexes in the magnitude of the enzyme-inducing
effect. The increased enzyme activity in females (200%) was
about fivefold greater than the increase observed in males (37%)
(Table II).
6
E2-OH activity is expressed as pmol methoxy-oestrogen per mg microsomal protein
formed per 10 min at 3r C. Cytochrome P-450 concentration is given in nmol per mg
microsomal protein.
TABLE II. COMPARISON OF E2-OH AND TOTAL
CYTOCHROME P-450 INDUCTION IN LIVERS OF MALE
AND FEMALE RATS
Treatment
None
Phenobarbitone
% induction
Male
E2-OH Cyt. P-450
1477 0,60
2029 1,05
+37% +75%
Female
E2-OH Cyt. P-450
367 0,45
1108 0,82
+200% +82%
-- 0,1 0,2
1~
Effect of phenobarbitone treatment on total
cytochrome P-450 in liver microsomes
There is evidence that E,-OH belongs to the microsomal
cytochrome P-450 group of ri1ono-oxygenases. 7,8 In view of this
we were interested in finding out whether induction of
cytochrome P-450 in liver microsomes could be correlated with
the induction of E2-OH activity. The values for cytochrome P-
450 in liver microsomes of control and phenobarbitone-treated
rats are given in Table II. As can be seen, microsomes from male
rats contained slightly more cytochrome P-4S0 than those from
females, In both sexes phenobarbitone caused a substantial
increase in the amount of cytochrome P-4S0, but there was no
significant difference between males and females in the
magnitude of induction when compared with the respective
control values.
Fig. 2. Effect of phenobarbitone treatment on apparent Km of E2-O H in liver
microsomes of female rats. The plot represents one experiment. Closed
circles: control (Km = 12,5 }lM); open circles: phenobarbitone-treated
animals (Km = 21,5 }lM). Values for ltv were multiplied by 103•
TABLE III. EFFECT OF PHENOBARBITONE ON THE
APPARENT Km OF E2-OH IN LIVER
Male Female
Treatment Mean SEM Mean SEM
None 9,8 ±0,564 9,2 ±3,300
(4) (2)
Phenobarbitone 8,15 ±0,050 18,7 ±2,85
(2) (2)
K,,\ values are given in p.M and were obtained from Lineweaver-Burke plots as shown
in Figs. 1 and 2. The values represent the means obtained from the number of
experiments shown in brackets
1.5
Fig. 1. Effects 9f phenobarbitone treatment on apparent Km of E2-OH in
liver microsomes of male rats. The plot represents one experiment. Closed
circles: control (K m = 11,4 }lM); open circles: phenobarbitone-treated
animals (Km = 8,2 }lM). Values for ltv were multiplied by 103.
In the present study we have confirmed earlier observations7,8
which indicate that rat brain tissue contains E2-OH. Although
the function of this enzyme in the brain is not known, there is
growing evidence that it may be involved in neuro-endocrine
regulation through its ability to form catechol oestrogens. Some
of this evidence has been summarized in a recent review9 and
research papers. 16,17 The catechol oestrogens may conceivably
affect neuro-endocrine funcrion by virtue of their oestrogenic or
anti-oestrogenic properties.9 Another possibility i, that they
could affect the hypothalamic-pituitary axis by inhibiting
catecholamine synthesis. Evidence for this possibility is the
observation that catechol oestrogens inhibit tyrosine
hydroxylase activity in hypothalamic extracts. 18
Since there is evidence that E2-OH belongs to the cytochrome
P-450 group of mono-oxygenases, the question arises whether its
activity in the brain is inducible by drugs. In the present study
phenobarbitone had no statistically significant effect on E 2-OH
activity in the brain. Hoffman el al. 8 also found that cytochrome
P-450 inducers did not increase the activity ofthis enzyme in the
brain. They did, however, find evidence for hormonal effects on
its activity. Thus castration caused a fall in enzyme activity in
both liver and brain tissue of male rats, Hoffman el al. 8 also
observed a higher Ez-OH activity in the brains of males than in
those of females, but we were unable, in the presem study, to
confirm these sex differences. Although the reason for these
contradictory results is not clear to us, there is at least one
important factor which could influence comparisons between
male and female rats, and that is the oestrus cycle, Fishmanel al. 5
Discussion
~,20,1o
1,0
Effect ofphenobarbitone treatment on enzyme
kinetics
In an attempt to gain more insight into the sexual differences
in E2-OH induction we measured the apparent K m of the enzyme
in control and phenobarbitone-treated rats, The results of these
experiments are shown in Figs 1 and 2 and in Table III. In males
phenobarbitone tended to decrease the apparent Km (Fig. 1). In
females, on the other hand, we observed an increase in the K m
values over those of control animals (Fig. 2).
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have reported significant changes in ~-OH activiry in the brains
of female rats during the oestrus cycle. During oestrus, for
example, enzyme activity was nearly 6 times higher than during
di-oestrus.
The stimulatory effect of phenobarbitone on E2-OH activiry
in the liver is in sharp contrast to its inabiliry to induce this
enzyme in the brain. Percy and Shanley l9 have also found that
phenobarbarbitone does not induce cytochrome P-450 in the
microsomes or mitochondria of rat brain. Furthermore, Liem er
al. 20 have reported tissue specificity with respect to the induction
of certain forms of cytochrome P-450.
To our knowledge the induction of hepatic E2-OH activity by
phenobarbitone has not been reported before. In fact, other
workers have been unable to induce this steroid-metabolizing
enzyme in the liver of male rats with phenobarbitone or 3-
methylcholanthrene.s-21 On the other hand, the induction of
several other steroid-metabolizing enzymes has been
described. 10,22,23 The fact that phenobarbitone and other
clinically used drugs may alter the metabolism of steroids is of
practical concern to physicians and the importance of this is
attested to by a recent review. 10
A very interesting observation in our present study was that
phenobarbitone' affected the kinetic characteristics of Eo-OH
differently in male and female rats. It caused a significant
increase in enzyme activity (Vmax) in both sexes, but with the
increased activity in females about fivefold greater than in males.
Secondly, phenobarbitone treatment tended to decrease the
apparent Km of the enzyme in males and to increase it in females.
The changes in the mean Km values for each sex did not reach
statistical significance with the small number of experiments
reported here. Nevertheless the relatively large differences seen
in individual experiments with female rats were highly
suggestive of a real effect of phenobarbitone on the Km.
The possibiliry that phenobarbitone has different effects on
the kinetic characteristics of E2-OH in males and females is
interesting, particularly in view of the fact that the Vmax and Km
of other steroid-metabolizing enzymes show sex-dependent
differences.' Also important in this context is the finding by
Chung2 that the Km and Vmax ofethylmorphine N-demethylase
in liver microsomes are both imprinted by androgens in the
neonatal male rat, but that the sensitive periods for imprinting of
the two kinetic characteristics differ. Furthermore, the
maintenance of the imprinted Km and Vmax requires the presence
of an intact pituitary gland.
In female rats an increased Km and Velax associated with
phenobarbitone treatment may reflect the induction of a form of
cytochrome P-450 which hydroxylates oestradiol, but with a
lower affinity towards this substrate. It is now widely accepted
that there are multiple forms of cytochrome P-450, each with its
own spectrum of activity towards endogenous substrates and
foreign compounds.20,21 Furthermore. more than one form of
cytochrome P-450 may be active towards the same substrate.
Kremers er al. 24 studied steroid loo-hydroxylase activities in
normal and phenobarbitone-treated rats and used four different
substrates to meaSllre enzvme activity. They concluded that
steroid loo-hydroxylase activity may be due to at least two
different forms of cytochrome P-450. Some of the observations
which these authors made are remarkably similar to our findings.
The activity of l6a-hydroxylase with pregnenolone as substrate,
for example, was differently induced by phenobarbitone in males
and females. In females the induced enzyme activity was roughly
tenfold higher than control values, whereas the induced activity
in males was only about twofold higher than control values.
Kremers er al. 24 also found, as we did, that the variations in
inducibility and in male-female enzyme activity ratios could not
be directly correlated with changes in the toral cytochrome P-450
content of microsomes.
While we need more evidence on this point, it is tempting to
explain our findings in terms of factors which control neonatally
imprinted sexual differences in the adult animal. Sex-dependent
differences in the oxidative metabolism of several endogenous
steroids have been reported. 1,2 Although relatively little is known
about this form of sexual dimorphism, some of the major factors
which appear to control it have been identified. The basic
masculine or feminine patterns of steroid metabolism are
established soon after birth by the gonadal steroids to which the
young animal is exposed. Thus the male panern in rats depends
on the presence of testosterone, whereas. the female pattern
develops in the absence of testosterone. 4 In addition to neonatal
imprinting there are also two known factors which are necessary
to maintain sexual dimorphism in the adult animal. These factors
are the pituitary gland and the circulating sex steroids.
Castration of male rats, or testosterone treatment of females, fOf
example, results in decreases or increases of hepatic steroid and
drug metabolism. 2 Hypophysectomy of female rats leads to a
drug-metabolizing pattern in the liver which resembles that of
the male. 2>
In conclusion, and as a final summary of our present findings,
we would like to propose the following working hypothesis: sex-
dependent differences in E2-OH activity in rat liver are
imprinted neonarally and the male and female patterns of
enzyme activity are maintained by the pituitary gland.
Phenobarbitone treatment may affect E2-OH activity in the liver
by a dual mechanism, i.e. through suppression of the
hypothalamic-piruitary axis and by direct induction of the
enzyme. Whether these effects of phenobarbitone are implicated
in long-term changes in female reproductive function of rats
exposed to phenobarbitone in lI£ero ll remains to be established.
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